Articles
Summary of FDA’s “Report on the State of Pharmaceutical Quality: Fiscal year 2021”
By Mark Land, M.S., RAC, AAHP President Introduction In August of 2022, the United States Food and Drug Administration (FDA) published its fourth annual Report on the State of Pharmaceutical…
Read MoreMore Snapshots From the There and Then
Ukraine Homeopathy had a firm foundation in Ukraine during Hahnemann’s lifetime. With the support and public use by Russian royalty, prominent aristocrats, and merchants. and other public figures. The use…
Read MoreWhat’s new at FDA?
The United States Food and Drug Administration is a large organization that changes daily. From the perspective of homeopathic companies, a few important things stand out. FDA published the final…
Read MoreAAHP Reader Favorites for 2022
As we enter 2023, it’s time to look back at our top articles of 2022. These five pieces were the most-read content over the past year. Thank you for your…
Read More2023 Marks 100 Years of Success
By Mark Land, AAHP President This year AAHP turns 100 years old. Over that time, our association has represented the interests of homeopathic manufacturers with one goal in mind: Enabling…
Read MoreSnapshots From the There and Then
In honor of AAHP’s 100th Anniversary (1923–2023) year, we look back at the history of homeopathy to find out how this medical modality spread around the world. One also discovers…
Read MoreFTC Updates Health Claims Substantiation Guidance
By Alvin J. Lorman, AAHP Legal Counsel In December 2022, the Federal Trade Commission released a lengthy guidance document on the substantiation it expects for health claims, Health Products Compliance…
Read MoreFDA Finalizes Homeopathic Guidance
By Alissa Gould, AAHP Communications Chair Seven years after the U.S. Food and Drug Administration (FDA) held a public hearing on homeopathic product regulation and two rounds of public comments,…
Read MoreFTC Proposes Making Rules Affecting Endorsements and Testimonials
By Alvin Lorman, AAHP Counsel Calling fake and deceptive product reviews and endorsements “problematic” and its remedial authority “limited,” the Federal Trade Commission (FTC) has taken the first step toward…
Read MoreIndustry Leader Spotlight: Sandra Chase, M.D.
By Eric Foxman, with thanks to Nick Nossaman, M.D., and the American Institute of Homeopathy for the basis of this profile. In reviewing Dr. Sandra Chase’s career in homeopathy, one…
Read More